StreetInsider.com News Articles

Form 4 Solid Biosciences Inc. For: Jul 02 Filed by: SMITH IAN F

Tue, 07 Jul 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260707/26741792.html

Form 4 Solid Biosciences Inc. For: Jul 02 Filed by: SMITH IAN F

Tue, 07 Jul 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260707/26741792.html

Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens

Tue, 07 Jul 2026 05:21:09 -0400

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).

The analyst commented, "This Thursday (July 9) at 10 a.m. ET, we will host FARA CEO Jennifer Farmer to discuss recent developments in the Friedreich’s Ataxia (FA) pipeline on the heels of updated data from Larimar Therapeutic’s ongoing open-label trial of nomlabofusp; we reiterate our Market Outperform rating and $18 risk-adjusted, DCF-derived price target. Ms. Farmer will be able to provide additional context on nomlabofusp’s perceived benefit/risk profile from the patient community perspective. Additionally, we plan to discuss real world feedback on Skyclarys’

Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens

Tue, 07 Jul 2026 05:21:09 -0400

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).

Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens

Tue, 07 Jul 2026 05:21:09 -0400

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).

Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens

Tue, 07 Jul 2026 05:21:09 -0400

Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).

Form 3 Solid Biosciences Inc. For: Jun 22 Filed by: Kolchinsky Peter

Wed, 24 Jun 2026 18:50:00 -0400

si-local-file:///var/storage/secattach/20260624/26686754.html

Form 3 Solid Biosciences Inc. For: Jun 22 Filed by: Kolchinsky Peter

Wed, 24 Jun 2026 18:50:00 -0400

si-local-file:///var/storage/secattach/20260624/26686754.html

Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Wed, 24 Jun 2026 18:49:00 -0400

si-local-file:///var/storage/secattach/20260624/26686751.html

Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.

Wed, 24 Jun 2026 18:49:00 -0400

si-local-file:///var/storage/secattach/20260624/26686751.html

Form 4 Solid Biosciences Inc. For: Jun 10 Filed by: EDELMAN JOSEPH